...
机译:Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
Department of Medicine, Memorial Sloan Kettering Cancer Center;
Department of Radiology, Memorial Sloan Kettering Cancer Center;
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center;